A US$1 billion CHIPS Act award will fund quantum semiconductor foundry development at Anderon, with Clifford Chance serving as legal counsel to the U.S. Department of Commerce on the transaction.

Clifford Chance disclosed the award without specifying a closing date, drawdown schedule, or technical parameters for the foundry build-out. The firm confirmed the engagement covers Commerce's role in awarding the funding.

What is the structure of the engagement?

Clifford Chance is advising Commerce — not the recipient — placing the firm on the government side of one of the larger CHIPS Act allocations to date. The CHIPS and Science Act, signed into law in August 2022, authorizes Commerce to negotiate, award, and monitor federal funding for domestic semiconductor manufacturing, research, and workforce programs.

Awards at the $1 billion tier typically include binding milestones covering:

• Construction phase completions
• Production capacity thresholds
• Headcount and workforce commitments
• Domestic sourcing requirements for equipment and materials

The Clifford Chance statement did not specify which conditions apply to the Anderon award or whether the $1 billion will be disbursed as a single tranche or staged payments.

What is known about the recipient?

Anderon appears in the Clifford Chance headline without accompanying corporate disclosure. The announcement identifies no company headquarters, leadership names, existing foundry footprint, or fab-equipment partners. The lack of detail leaves open whether Anderon is a new venture, a unit of a larger semiconductor group, or an existing specialty foundry operator entering the quantum segment.

The company's absence from prior CHIPS Act award announcements suggests the quantum foundry project represents its first publicly disclosed federal allocation.

Why quantum semiconductor manufacturing?

Quantum semiconductor foundries target chip designs intended for quantum computing systems. Production lines typically focus on:

• Cryogenic control electronics
• Qubit interconnect structures
• Dilution-refrigerator-compatible packaging
• Specialized lithography processes distinct from mainstream CMOS production

Domestic capacity for these components has been a recurring focus of Commerce allocation strategy. The announcement does not specify qubit modalities, process nodes, or substrate materials the Anderon facility will handle.

What are the next milestones?

Clifford Chance's disclosure indicates the engagement remains active. Commerce has not released a parallel statement identifying award conditions, co-funding requirements, or restrictions tied to customer concentration. The quantum semiconductor foundry sector has drawn multiple CHIPS Act applicants since 2023, but Anderon has not previously surfaced in publicly tracked award databases.

What's the broader market context?

Quantum computing hardware supply chains remain fragmented. Commercial qubit production concentrates in superconducting and trapped-ion modalities. A U.S. foundry for quantum semiconductor components would address the absence of high-volume domestic manufacturing for control and interconnect electronics that operate at near-absolute-zero temperatures.

The $1 billion figure positions this award alongside other large-scale CHIPS Act allocations for advanced-node logic and memory fabs, which have drawn multibillion-dollar awards since 2023. The quantum allocation is the first publicly disclosed CHIPS Act award at this scale for a foundry specifically targeting quantum semiconductor components.

Commerce's CHIPS Office typically publishes individual award fact sheets following preliminary memoranda of terms. No such sheet has appeared for Anderon at the time of the Clifford Chance announcement.